Head-to-head comparison
Sermorelin vs Tesamorelin
Physician-reviewed comparison
Sermorelin
Clinical DataLegal to Compound
A GHRH analog that stimulates natural growth hormone release from the pituitary gland.
Tesamorelin
Peer ReviewedFDA Approved
An FDA-approved GHRH analog indicated for HIV-associated lipodystrophy.
Quick Comparison
| Dimension | Sermorelin | Tesamorelin |
|---|---|---|
| Category | growth hormone secretagogue | growth hormone secretagogue |
| Classification | Growth Hormone Releasing Hormone Analog | Growth Hormone Releasing Hormone Analog |
| Evidence Rating | Clinical Data | Peer Reviewed |
| Regulatory Status | Legal to Compound | FDA Approved |
| Delivery | Subcutaneous injection | Subcutaneous injection |
| Complexity | 4 / 5 | 4 / 5 |
| Refrigeration | Required | Required |
Dosing Comparison
Sermorelin
GH Optimization (Clinic Protocol)
200–500 mcg · daily
Tesamorelin
HIV Lipodystrophy (FDA-Approved)
1.4–2 mg · daily
Body Composition (Off-Label)
1–2 mg · daily
Can You Stack Them?
No known direct interaction between Sermorelin and Tesamorelin in our database. However, always consult your provider before combining compounds.
Medical Disclaimer
This comparison is for educational purposes only. Individual responses vary. Consult a qualified healthcare provider before using any compound.